Inactive Instrument

DERMAdoctor, LLC.

DDOC

US24983G1058

DERMAdoctor, Inc. Announces Dr. Jeff Kunin to Retire and Resign from His Position as the President, Effective as of November 5, 2023

July 07, 2023 at 10:00 pm

On July 6, 2023, Dr. Jeff Kunin advised NovaBay Pharmaceuticals, Inc. of his decision to retire and resign from his position as the President of DERMAdoctor, LLC, the Companyâ€™s wholly owned subsidiary, effective as of November 5, 2023, the natural expiration of his Executive Employment Agreement, dated November 5, 2021.

Latest news about DERMAdoctor, LLC.

New Age Investments LLC completed the acquisition of DERMAdoctor, Inc. from NovaBay Pharmaceuticals, Inc..	03-24	CI
New Age Investments LLC entered into a Membership Unit Purchase Agreement to acquire DERMAdoctor, Inc. from NovaBay Pharmaceuticals, Inc. for $1.07 million.	03-13	CI
DERMAdoctor, Inc. Announces Dr. Jeff Kunin to Retire and Resign from His Position as the President, Effective as of November 5, 2023	07/07/23	CI
DERMAdoctor, LLC Reports Earnings Results for the Nine Months Ended September 30, 2021	01/12/21	CI
NovaBay Pharmaceuticals, Inc. completed the acquisition of DERMAdoctor, LLC from Jeff Kunin, Audrey Kunin and Midwest Growth Partners, LLLP, a fund managed by Midwest Growth Partners, LLLP.	04/11/21	CI
NovaBay Pharmaceuticals, Inc. entered into a Membership Unit Purchase Agreement to acquire DERMAdoctor, LLC from Jeff Kunin, Audrey Kunin and Midwest Growth Partners, LLLP, a fund managed by Midwest Growth Partners, LLLP, for $15 million.	27/09/21	CI
DERMAdoctor, Inc. has withdrawn its IPO in the amount of $12.35 million.	11/09/19	CI
DERMAdoctor, Inc. has filed an IPO in the amount of $16.875 million.	02/05/18	CI
DERMAdoctor, Inc. announced that it has received $3.5 million in funding.	19/01/16	CI
DERMAdoctor, Inc. announced that it expects to receive $3.5 million in funding.	31/12/15	CI
DERMAdoctor, Inc. Appoints Gabrielle Bridges as Executive Vice President of Sales	30/09/15	CI

Chart DERMAdoctor, LLC.

Duration

Period

More charts

Company Profile

Papillon Partners, Inc., formerly DERMAdoctor, Inc., is an omni-channel skincare company that develops skincare products for common skin concerns. The Company's products target skin concerns that include aging, wrinkles, acne, redness, blemishes, dry skin, perspiration, dark circles, pigmentation, eczema and keratosis pilaris. It develops and markets its skincare products under the brand name, DERMAdoctor. The Company's product family includes Wrinkle Revenge, Ain't Misbehavin', Calm Cool and Corrected and KP Duty. The product families are further broken down to face, eyes and body. The Company also develops skincare products such as, facial cleansers, sunscreens, moisturizers, facial exfoliants, chemical peelers, serums, night creams and eye creams.

Sector

Personal Products

More about the company

Sector Other Personal Products

	1st Jan change	Capi.
PROCTER & GAMBLE COMPANY	+14.51%	396B
UNILEVER PLC	+13.71%	136B
COLGATE-PALMOLIVE COMPANY	+18.88%	77.74B
HINDUSTAN UNILEVER LIMITED	-10.61%	66.79B
ESTEE LAUDER	-10.58%	46.89B
KENVUE INC.	-7.66%	38.07B
BEIERSDORF	+7.59%	35.65B
ESSITY AB	+10.76%	18.19B
GODREJ CONSUMER PRODUCTS LIMITED	+16.69%	16.04B

Other Personal Products